Addressing new psychoactive substances, amphetamine-type stimulants, including methamphetamine, the diversion of precursors and pre-precursors and the non-medical use and misuse of pharmaceuticals containing narcotic drugs and psychotropic substances
country: {{country}}
recommendation: {{recommendation}}
initiative: {{initiative}}
implementer: {{implementer}}
status: {{status}}
links: {{link}}
--> detail
